Integrated Stress Response Mediates Epithelial Injury in Mechanical Ventilation

Am J Respir Cell Mol Biol. 2017 Aug;57(2):193-203. doi: 10.1165/rcmb.2016-0404OC.

Abstract

Ventilator-induced lung injury (VILI) is a severe complication of mechanical ventilation that can lead to acute respiratory distress syndrome. VILI is characterized by damage to the epithelial barrier with subsequent pulmonary edema and profound hypoxia. Available lung-protective ventilator strategies offer only a modest benefit in preventing VILI because they cannot impede alveolar overdistension and concomitant epithelial barrier dysfunction in the inflamed lung regions. There are currently no effective biochemical therapies to mitigate injury to the alveolar epithelium. We hypothesize that alveolar stretch activates the integrated stress response (ISR) pathway and that the chemical inhibition of this pathway mitigates alveolar barrier disruption during stretch and mechanical ventilation. Using our established rat primary type I-like alveolar epithelial cell monolayer stretch model and in vivo rat mechanical ventilation that mimics the alveolar overdistension seen in acute respiratory distress syndrome, we studied epithelial responses to mechanical stress. Our studies revealed that the ISR signaling pathway is a key modulator of epithelial permeability. We show that prolonged epithelial stretch and injurious mechanical ventilation activate the ISR, leading to increased alveolar permeability, cell death, and proinflammatory signaling. Chemical inhibition of protein kinase RNA-like endoplasmic reticulum kinase, an upstream regulator of the pathway, resulted in decreased injury signaling and improved barrier function after prolonged cyclic stretch and injurious mechanical ventilation. Our results provide new evidence that therapeutic targeting of the ISR can mitigate VILI.

Keywords: alveolar epithelium; integrated stress response; ventilator-induced lung injury.

MeSH terms

  • Activating Transcription Factor 4 / antagonists & inhibitors
  • Activating Transcription Factor 4 / genetics
  • Activating Transcription Factor 4 / physiology
  • Adenine / analogs & derivatives
  • Adenine / pharmacology
  • Adenine / therapeutic use
  • Alveolar Epithelial Cells / metabolism
  • Alveolar Epithelial Cells / pathology*
  • Animals
  • Cell Death
  • Cell Membrane Permeability
  • Cells, Cultured
  • Cytokines / metabolism
  • Drug Evaluation, Preclinical
  • Enzyme Activation
  • Gene Expression Regulation
  • Indoles / pharmacology
  • Indoles / therapeutic use
  • Protease Inhibitors / pharmacology
  • Protease Inhibitors / therapeutic use
  • Pulmonary Edema / drug therapy
  • Pulmonary Edema / etiology
  • RNA Interference
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Stress, Mechanical
  • Stress, Physiological / physiology*
  • Transcription Factor CHOP / antagonists & inhibitors
  • Transcription Factor CHOP / genetics
  • Transcription Factor CHOP / physiology
  • Unfolded Protein Response
  • Ventilator-Induced Lung Injury / physiopathology*
  • eIF-2 Kinase / antagonists & inhibitors
  • eIF-2 Kinase / genetics
  • eIF-2 Kinase / physiology

Substances

  • 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine
  • Atf4 protein, rat
  • Cytokines
  • Ddit3 protein, rat
  • Indoles
  • Protease Inhibitors
  • Activating Transcription Factor 4
  • Transcription Factor CHOP
  • PERK kinase
  • eIF-2 Kinase
  • Adenine